Société Sigilon Therapeutics, Inc.
Actions
SGTX
US82657L2060
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 62
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 60 | 14/08/18 | |
Director of Finance/CFO | 58 | 01/11/19 | |
Philip Johnson
PSD | President | 59 | 11/08/23 |
Bernd Kullmann
COO | Chief Operating Officer | - | - |
Qing Sarah Yuan
CTO | Chief Tech/Sci/R&D Officer | 53 | 07/03/22 |
Chief Tech/Sci/R&D Officer | 60 | 14/06/21 | |
Chief Administrative Officer | 52 | 01/01/19 | |
Michael Thompson
BRD | Director/Board Member | - | 11/08/23 |
Robert Windsor
IRC | Investor Relations Contact | - | 01/05/21 |
Chris Anderson
SEC | Corporate Secretary | - | 11/08/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 60 | 14/08/18 | |
Philip Johnson
PSD | President | 59 | 11/08/23 |
Gordon Brooks
BRD | Director/Board Member | - | 11/08/23 |
Michael Thompson
BRD | Director/Board Member | - | 11/08/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 2 502 084 | 2 294 190 ( 91,69 %) | 0 | 91,69 % |
Coordonnées société
![Adresse Sigilon Therapeutics, Inc.(SGTX)](https://cdn.zonebourse.com/static/address/116081124.png)
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+19,41% | 45,51 Md | |
-8,62% | 38,52 Md | |
+38,65% | 38,13 Md | |
+26,95% | 30,74 Md | |
-13,50% | 26,03 Md | |
+10,74% | 25,92 Md | |
+44,87% | 14,13 Md | |
+34,36% | 12,73 Md | |
-7,14% | 11,29 Md |